Microbicide applicators: Understanding design preferences among women in the Dominican Republic and South Africa

Sexually Transmitted Diseases

Volumn 34, Issue 1, 2007, Pages 15-19

  Cohen, Jessica A ^a,d   Steele, Matthew S ^a   Ureña, Francisco I Cáceres ^b   Beksinska, Mags E ^c  

^a PATH   (United States)

^b PROFAMILIA   (Dominican Republic)

^c Reproductive Health Research Unit   (South Africa)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE;

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DOMINICAN REPUBLIC; DRUG COST; FEMALE; HEALTH BEHAVIOR; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOWEST INCOME GROUP; PATIENT COMPLIANCE; RANDOMIZATION; SOCIOECONOMICS; SOUTH AFRICA;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; DOMINICAN REPUBLIC; DRUG DELIVERY SYSTEMS; FEMALE; HIV INFECTIONS; HUMANS; PATIENT SATISFACTION; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; SOUTH AFRICA; WOMEN'S HEALTH;

EID: 33845977373     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000218877.92778.fe     Document Type: Article

References (15)

1. UNAIDS/PAHO/UNICEF/WHO. 2004 Update. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections: Dominican Republic. Available at: http://www.who.int/GlobalAtlas/predefinedReports/EFS2004/EFS_PDFs/EFS2004_DO. pdf. Accessed October 21, 2005.
2. UNAIDS/PAHO/UNICEF/WHO. 2004 Update. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections: South Africa. Available at: http://www.who.int/GlobalAtlas/predefinedReports/EFS2004/EFS_PDFs/EFS2004_ZA. pdf. Accessed October 21, 2005.
3. Mantell JE, Myer L, Carballo-Dieguiez A, et al. Microbicide acceptability research: Current approaches and future directions. Soc Sci Med 2005; 60:319-330.
4. Woodsong C. Covert use of topical microbicides: Implications for acceptability and use. Perspect Sex Reprod Health 2004; 36:127-131.
5. Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J Women's Health Gend Based Med 2001; 10:163-173.
6. Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4-country phase I trial. Am J Public Health 2004; 94:1159-1164.
7. Morrow K, Rosen R, Richter L, et al. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. J Women's Health 2003; 12:655-666.
8. Coetzee N, Blanchard K, Ellertson C, et al. Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides. AIDS 2001; 15:1837-1842.
9. Coggins C, Elias C, Atisook R, et al. Women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS 1998; 12:1389-1391.
10. Hardy E, Jimenez A, de Padua K, et al. Women's preferences for vaginal antimicrobial contraceptives: III. Choice of a formulation, applicator, and packaging. Contraception 1998; 58:245-249.
11. Vail J, Cohen JA, Kelly K. Improving topical microbicide applicators for use in resource-poor settings. Am J Public Health 2004; 94:1089-1092.
12. Le Page ME, Brown D Jr, Wells J. Patient acceptance of prefilled disposable vaginal applicator. Am J Obstet Gynecol 1998; 158:1006-1008.
13. Cohen J. Delivering microbicides: Considering key factors in applicator design. The Microbicide Quarterly 2004; 2:15-19.
14. Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: A systematic review of techniques. Health Technol Assess 2001; 5:1-186.
15. National HIV and Syphilis Antenatal Sero-Prevalence Survey in South Africa 2004. Department of Health, Pretoria, South Africa, 2005. Available at: http://www.doh.gov.za/docs/reports/2004/hiv-syphilis.pdf. Accessed October 21, 2005.